Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04249739 | Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive | unknown | Phase 2 | 93 | Samsung Medical CenterOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT04062656 | Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG(IMAGINE) | unknown | Phase 2 | 21 | University Hospital, EssenOTHER | 1 | Mar 12, 2024 |
| clinicaltrials |
| NCT06305169 | Measuring the Negative Predictive Value and Specificity of Serum Biomarkers in Gastric Cancer | unknown | — | 440 | Sandwell & West Birmingham Hospitals NHS TrustOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT05472857 | Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression | unknown | Phase 1 | 30 | Suzhou Immunofoco Biotechnology Co., LtdINDUSTRY | 1 | Mar 6, 2024 | clinicaltrials |
| NCT06284746 | Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer | unknown | Phase 2 | 80 | Lin ChenOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT01917552 | Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS | unknown | Phase 3 | 870 | Asan Medical CenterOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06281860 | Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration(PITHAC) | unknown | Phase 1 | 39 | Dr Jean Yannis PERENTESOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT05122091 | Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma | unknown | Phase 2 | 53 | Guangxi Medical UniversityOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06277453 | Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy | unknown | — | 219 | Fujian Medical UniversityOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06277908 | Postoperative Morbidity and Mortality After Gastric Cancer Surgery(GASTROSTAT) | unknown | — | 700 | P. Herzen Moscow Oncology Research InstituteOTHER_GOV | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06278064 | Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers Diagnosis | unknown | — | 562 | Beijing Friendship HospitalOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06075849 | Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent | unknown | Phase 1 | 30 | Panolos BioscienceINDUSTRY | 1 | Feb 23, 2024 | clinicaltrials |
| NCT06266871 | SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 64 | West China HospitalOTHER | 0 | Feb 20, 2024 | clinicaltrials |
| NCT03924466 | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients(VUBAR) | unknown | Phase 2 | 55 | Universitair Ziekenhuis BrusselOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT05028933 | IMC001 for Clinical Research on Advanced Digestive System Malignancies | unknown | Phase 1 | 48 | Zhejiang UniversityOTHER | 1 | Feb 12, 2024 | clinicaltrials |
| NCT05029102 | TAS-102 and Anlotinib in ≥3 Lines mGC | unknown | Phase 2 | 45 | Zhejiang UniversityOTHER | 1 | Feb 12, 2024 | clinicaltrials |
| NCT06254300 | Online Exercise Program During Perioperative Treatment in Adults With Gastric Cancer(On4Cancer) | unknown | N/A | 40 | University of MaiaOTHER | 1 | Feb 12, 2024 | clinicaltrials |
| NCT04149691 | Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies | unknown | Phase 1 | 42 | Celon Pharma SAINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT06235164 | The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer | unknown | — | 585 | Fujian Medical UniversityOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT06227325 | Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression | unknown | Phase 2 | 27 | Henan Cancer HospitalOTHER_GOV | 1 | Jan 26, 2024 | clinicaltrials |
| NCT06222944 | Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA | unknown | Phase 2 | 90 | Peking UniversityOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT06224738 | Human HER2-targeted Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal Metastases | unknown | Early Phase 1 | 9 | First People's Hospital of HangzhouOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT06169410 | Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer | unknown | Phase 4 | 140 | Yang Jianjun, PhDOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT06182644 | Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors(FAPI) | unknown | N/A | 30 | Guangdong Provincial People's HospitalOTHER | 1 | Jan 22, 2024 | clinicaltrials |
| NCT06204523 | Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer | unknown | — | 167 | Regina Elena Cancer InstituteOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT06194981 | Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage | unknown | — | 260 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT06202781 | Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy | unknown | — | 28 | Chinese PLA General HospitalOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT04500392 | High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity | unknown | N/A | 1,000 | RenJi HospitalOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06201585 | Exploratory Study of Single-port Robot-assisted Gastrectomy | unknown | N/A | 10 | Hebei Medical UniversityOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06196554 | Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs | unknown | — | 40 | Dong Bing ZhaoOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT06197438 | Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer | unknown | Phase 2 | 36 | Fujian Cancer HospitalOTHER_GOV | 0 | Jan 9, 2024 | clinicaltrials |
| NCT02037048 | FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma | unknown | Phase 2 | 63 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT05859477 | Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer(NIVOFGFR2) | unknown | Phase 2 | 23 | Kidney Cancer Research BureauOTHER | 1 | Jan 2, 2024 | clinicaltrials |
| NCT04714190 | A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression | unknown | Phase 3 | 351 | RemeGen Co., Ltd.INDUSTRY | 1 | Dec 21, 2023 | clinicaltrials |
| NCT06163365 | Inherited Cancer Early Diagnosis (ICED) Study(ICED) | unknown | — | 100 | Royal Marsden NHS Foundation TrustOTHER | 1 | Dec 8, 2023 | clinicaltrials |
| NCT06152783 | Confocal Laser Microendoscopy (CellTouch) for the Diagnosis of Early Gastric Cancer: A Multicenter Clinical Study | unknown | — | 578 | Changhai HospitalOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT06149923 | Association Between ABO Polymorphism and Gastric/Colorectal Cancers | unknown | — | 184 | Assiut UniversityOTHER | 0 | Nov 29, 2023 | clinicaltrials |
| NCT02139605 | "Phase III Randomized Trial Comparing D2 vs D3 Lymphadenectomy With Gastric Cancer Following Neoadjuvant Chemotherapy | unknown | N/A | 400 | Tata Memorial CentreOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT06134011 | A Multi-omics-based Metabolic Typing Study of Gastric Cancer | unknown | — | 480 | Zhejiang Cancer HospitalOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT04999332 | Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer(LOTS) | unknown | Phase 2 | 58 | National Cheng-Kung University HospitalOTHER | 1 | Nov 15, 2023 | clinicaltrials |
| NCT04308837 | A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation | unknown | Phase 2 | 29 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Nov 14, 2023 | clinicaltrials |
| NCT06123637 | Analgesia Nociception Index-guided Anesthesia and Standard Anesthesia | unknown | N/A | 68 | Ajou University School of MedicineOTHER | 0 | Nov 9, 2023 | clinicaltrials |
| NCT04223401 | Prehabilitation for Gastrectomy(PREFOG) | unknown | N/A | 128 | National Cancer Center Affiliate of Vilnius University Hospital Santaros KlinikosOTHER | 1 | Nov 8, 2023 | clinicaltrials |
| NCT06123455 | Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer | unknown | Phase 2 | 60 | Tang-Du HospitalOTHER | 1 | Nov 8, 2023 | clinicaltrials |
| NCT06102746 | Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine Carcinoma | unknown | — | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT06098898 | Safety and Efficacy of NK510 to Treat Gastric Cancer | unknown | Early Phase 1 | 9 | Base Therapeutics (Shanghai) Co., Ltd.INDUSTRY | 1 | Oct 25, 2023 | clinicaltrials |
| NCT05229874 | Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomy(FUTURE-01) | unknown | Phase 2 | 96 | Hebei Medical UniversityOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT03129139 | A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors(Minnelide 101) | unknown | Phase 1 | 66 | Minneamrita Therapeutics LLCINDUSTRY | 1 | Oct 18, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Mar 13, 2024source: clinicaltrials